1783.TW · MBI
Taiwan · RS rating 30 · As of 2026-10-08
| Price | 38.10 TWD |
|---|---|
| 1-day change | -1.2% |
| RS rating (overall / 1M / 3M / 12M) | 30 / 50 / 41 / 32 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 38 / 23 / 57 |
| Industry group (rank) | Biotechnology & Medical Care (50) |
| EPS growth Q/Q | +51.7% |
| Sales growth Q/Q | +15.8% |
| Distance from 52-week high | +20.5% |
| Market cap (USD) | $104.1M |